Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eyeaze Lyte 0.1% eye drops preservative free
21300000987
|
Eyeaze Lyte 0.1% eye drops preservative free | Eye Products | Appliances | 1 |
|
Eytazox 250mg modified-release capsules
1106000B0BCAAAL
|
Eytazox | Acetazolamide | Eye | 1 |
|
Fampridine 10mg modified-release tablets
1002010U0AAABAB
|
Fampridine | Fampridine | Musculoskeletal and Joint Diseases | 1 |
|
Fareston 60mg tablets
0803041U0BBAAAA
|
Fareston | Toremifene citrate | Malignant Disease and Immunosuppression | 1 |
|
FarlaFIBRE Ribbon dressing 2cm x 45cm
20030000020
|
FarlaFIBRE Ribbon dressing 2cm x 45cm | Wound Management & Other Dressings | Dressings | 1 |
|
FarlaFOAM S dressing 7.5cm x 7.5cm
20033000025
|
FarlaFOAM S dressing 7.5cm x 7.5cm | Wound Management & Other Dressings | Dressings | 1 |
|
FemCap 30mm
21040000432
|
FemCap 30mm | Contraceptive Devices | Appliances | 1 |
|
Femulen 500microgram tablets
0703021C0BBAAAA
|
Femulen | Etynodiol diacetate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1 |
|
Fenhuma 200microgram sublingual tablets
0407020A0BXAFAX
|
Fenhuma | Fentanyl | Central Nervous System | 1 |
|
Fentalis Reservoir 100micrograms/hour transdermal patches
0407020A0BGADAH
|
Fentalis | Fentanyl | Central Nervous System | 1 |
|
Fentalis Reservoir 25micrograms/hour transdermal patches
0407020A0BGAAAE
|
Fentalis | Fentanyl | Central Nervous System | 1 |
|
Fentalis Reservoir 75micrograms/hour transdermal patches
0407020A0BGACAG
|
Fentalis | Fentanyl | Central Nervous System | 1 |
|
Fentanyl 50micrograms/dose nasal spray
0407020A0AABHBH
|
Fentanyl | Fentanyl | Central Nervous System | 1 |
|
Fenticonazole 600mg vaginal capsules
0702020I0AAADAD
|
Fenticonazole nitrate | Fenticonazole nitrate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1 |
|
Ferinject 1000mg/20ml dispersion for injection vials
0901012P0BBACAC
|
Ferinject | Iron carboxymaltose | Nutrition and Blood | 1 |
|
Ferric carboxymaltose 100mg/2ml inj vials
0901012P0AAAAAA
|
Iron carboxymaltose | Iron carboxymaltose | Nutrition and Blood | 1 |
|
FerroDose-F 305mg capsules
0901011F0BGABAH
|
FerroDose-F | Ferrous fumarate | Nutrition and Blood | 1 |
|
FerroDose-F 322mg tablets
0901011F0BGACAL
|
FerroDose-F | Ferrous fumarate | Nutrition and Blood | 1 |
|
Ferrograd C modified-release tablets
0901011C0BDAAAC
|
Ferrograd C | Compound iron preparations | Nutrition and Blood | 1 |
|
Ferrous citrate 62mg tablets
090101100AAAVAV
|
Generic compound preparation BNF 0901011 | Other oral iron preparations | Nutrition and Blood | 1 |
|
Ferrous sulfate 625mg/5ml oral liquid
0901011P0AABQBQ
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | 1 |
|
Fersaday 322mg tablets
0901011F0BBAAAL
|
Fersaday | Ferrous fumarate | Nutrition and Blood | 1 |
|
Fexofenadine 30mg/5ml oral suspension
0304010E0AAAGAG
|
Fexofenadine hydrochloride | Fexofenadine hydrochloride | Respiratory System | 1 |
|
Finasteride 1mg tablets
1309000W0AAAAAA
|
Finasteride (Scalp) | Finasteride | Skin | 1 |
|
Firmagon 120mg inj vials
0803042R0BBABAB
|
Firmagon | Degarelix | Malignant Disease and Immunosuppression | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.